# Sleep Apnea: Mechanism and Cerebrovascular Consequences

> **NCT00108602** · NA · WITHDRAWN · sponsor: **US Department of Veterans Affairs**

## Conditions studied

- Sleep Apnea, Obstructive
- Stroke

## Interventions

- **DRUG:** acetazolamide

## Key facts

- **NCT ID:** NCT00108602
- **Lead sponsor:** US Department of Veterans Affairs
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-05
- **Primary completion:** 2007-05
- **Final completion:** 2007-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** This study of the overall grant was not pursued as the aims were changed
- **Last updated:** 2015-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00108602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00108602, "Sleep Apnea: Mechanism and Cerebrovascular Consequences". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00108602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*